Ex Parte Donoho et al - Page 3


                  Appeal 2004-1103                                                                                              
                  Application 09/733,387                                                                                        
                  have been annotated as G protein-coupled receptors.  Appellants have not,                                     
                  however, demonstrated that their protein is a G protein-coupled receptor.  For the                            
                  reasons set forth in our June 30, 2004 Decision, appellants have not established                              
                  a utility for the sequence of claim 1.  Later filed publications cannot be used to                            
                  supplement an insufficient disclosure in an earlier application to render it                                  
                  enabling.  In re Glass, 492 F.2d 1228, 1232, 181 USPQ 31, 34 (CCPA 1974)                                      
                  (later publications which add to the knowledge of the art cannot be used to                                   
                  supplement an insufficient disclosure).  “It is an applicant’s obligation to supply                           
                  enabling disclosure without reliance on what others may publish after he has filed                            
                  an application on what is supposed to be a completed invention.  If he cannot                                 
                  supply enabling information, he is not yet in a position to file.”  Glass,                                    
                  492 F.2d at 1232, 181 USPQ at 34.  While the Glass court addressed the                                        
                  enablement requirement of § 112, the same rule applies to the utility requirement                             
                  of § 101.  In re Brana, 51 F.3d 1560, 1567 n.19, 34 USPQ2d 1436, 1441 n.19                                    
                  (Fed. Cir. 1995).                                                                                             
                          3.  Apparently, recognizing the deficiency in their argument regarding the                            
                  post-filing date references, appellants direct our attention to a murine sequence                             
                  that shares 68% identity and 78% similarity at the amino acid level of the entire                             
                  length of the sequence described in appellants’ specification and is present in                               
                  GenBank.  Request, page 2.  Again, sequence listings alone cannot establish a                                 
                  utility for the invention of claim 1.                                                                         
                          4.  According to appellants (id.), “third party scientists” annotated the                             
                  murine sequence present in GenBank as “‘Mus musculus Pb99 [(Pb99)] gene                                       
                  sequence’”.  See Brief, Exhibit F.  This annotation, alone, fails to establish a                              
                  utility for the invention of claim 1.                                                                         
                          5.  However, appellants assert that Sleckman3 functionally characterized                              
                  Pb99 as a G-protein coupled receptor.  While Sleckman published the same year                                 
                  as appellants’ filing date, we disagree with appellants that Sleckman                                         
                                                                                                                                
                  3 Sleckman et al. (Sleckman), “Cloning and Functional Characterization of the Early-Lymphocyte-               
                  Specific Pb99 Gene,” Molecular and Cellular Biology, Vol. 20, No. 12, pp. 4405-4410 (2000).                   
                  Brief, Exhibit G.                                                                                             

                                                               3                                                                


Page:  Previous  1  2  3  4  5  6  7  Next

Last modified: September 9, 2013